Clinical study of infertility treatment using platelet rich plasma (PRP) to endometrium.

Clinical study of infertility treatment using platelet rich plasma (PRP) to endometrium. - Clinical study of infertility treatment using platelet rich plasma (PRP) to endometrium.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030493

Enrollment

Registered

2017-12-25

Start date

2018-02-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sterility

Interventions

PRP Injection into uterus

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) The female patient who is undergoing infertility treatment, receives in vitro fertilization (IVF) or Intracyteplasmic sperm injection (ICSI) and schedules frozen embryo transplanting (FET) of the hormone replacement cycle. (2) The thickness of the endometrium is less than 7 mm. (3) Obtain informed consent from patient herself. (4) Age over 18 and under 50 (Freeze embryo until 42 years old)

Exclusion criteria

Exclusion criteria: (1) Patient with liver dysfunction (2) Hb less than 11g/dL (3) Platelet less than 150,000/mm3 (4) Patient using anticoagulation medicine. (5) Pregnant (6) Additionally something a study doctor in attendance judges to be unsuitable as a target of this research

Design outcomes

Primary

Measure	Time frame
Thickness of the endometrium	—

Secondary

Measure	Time frame
Safety Implantation rate	—

Countries

Japan

Contacts

Public ContactMaki Kusumi, M.D., Ph.D.

Sanno Hospital Reproduction Center

sannordc@gmail.com+81-3-3402-3151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026